Optimizing outcomes with less than more: multi-institutional experience of fast-forward fractionation and the impact of dosimetric parameters on toxicity in breast cancer patients - Summary - MDSpire

Optimizing outcomes with less than more: multi-institutional experience of fast-forward fractionation and the impact of dosimetric parameters on toxicity in breast cancer patients

  • By

  • H. Habibullah

  • M. Alotaibi

  • H. Almarzouki

  • Z. Mulla

  • M. Elbaiomy

  • R. Alahmadi

  • A. Ahmed

  • Y. Bahadur

  • R. Ujaimi

  • E. Senan

  • M. Attar

  • A. Bamakhramah

  • H. Altoukhi

  • H. Muamenah

  • O. Iskanderani

  • R. Garout

  • J. Alturkistani

  • H. Hijazi

  • Z. Jastaniah

  • June 10, 2026

  • 0 min

Share

Objective:

To report observed breast toxicities and examine the impact of dosimetric parameters in ultra-hypofractionated radiotherapy (RT) across a diverse patient population in Saudi Arabia.

Key Findings:
  • Remove any implications about treatment implications or benefits.
Interpretation:

Remove this section as it contains unsupported conclusions.

Limitations:
  • text
Conclusion:

Remove unsupported claims about optimizing dosimetric factors.

Original Source(s)

Optimizing outcomes with less than more: multi-institutional experience of fast-forward fractionation and the impact of dosimetric parameters on toxicity in breast cancer patients

  • by H. Habibullah, M. Alotaibi, H. Almarzouki, Z. Mulla, M. Elbaiomy, R. Alahmadi, A. Ahmed, Y. Bahadur, R. Ujaimi, E. Senan, M. Attar, A. Bamakhramah, H. Altoukhi, H. Muamenah, O. Iskanderani, R. Garout, J. Alturkistani, H. Hijazi, Z. Jastaniah

  • June 10, 2026

Related Content

Impact of body mass index on dietary habits and health behaviors in breast cancer patients

The gastrin-releasing peptide receptor in oncology: a comprehensive review of recent advances in targeted radionuclide theranostics

POC1A promotes malignant phenotypes in non-triple-negative breast cancer cell models with EMT- and Wnt/β-catenin-related alterations